Two Sigma Investments’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-11,300
Closed -$724K 3701
2018
Q4
$724K Sell
11,300
-58,900
-84% -$4.35M ﹤0.01% 1860
2018
Q3
$6.28M Sell
70,200
-255,300
-78% -$22.6M 0.02% 852
2018
Q2
$25.9M Buy
325,500
+225,100
+224% +$18.7M 0.08% 334
2018
Q1
$8.96M Buy
+100,400
New +$9.64M 0.03% 638
2017
Q4
Sell
-25,000
Closed -$3.65M 3678
2017
Q3
$3.65M Sell
25,000
-10,000
-29% -$1.36M 0.01% 968
2017
Q2
$4.54M Buy
35,000
+28,000
+400% +$3.43M 0.02% 903
2017
Q1
$871K Sell
7,000
-8,000
-53% -$957K ﹤0.01% 2003
2016
Q4
$1.74M Sell
15,000
-9,000
-38% -$1M 0.01% 1602
2016
Q3
$2.51M Sell
24,000
-17,000
-41% -$1.84M 0.01% 1305
2016
Q2
$4.04M Buy
41,000
+20,000
+95% +$2.07M 0.02% 861
2016
Q1
$2.1M Buy
21,000
+2,000
+11% +$206K 0.01% 1157
2015
Q4
$2.27M Buy
19,000
+13,000
+217% +$1.5M 0.01% 1026
2015
Q3
$649K Sell
6,000
-17,000
-74% -$2.11M ﹤0.01% 1415
2015
Q2
$2.66M Buy
+23,000
New +$2.63M 0.01% 1037

Other funds holding CELG

Two Sigma Investments's CELG Position: Q4 2019 in Review

Two Sigma Investments sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 741,969 shares — an estimated $73.7M sold.

Two Sigma Investments first reported a position in CELG in Q2 2013 and held it in 20 quarters. The position peaked at $183M in Q2 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Two Sigma Investments reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Two Sigma Investments sold 741,969 Celgene Corp shares in Q4 2019, an estimated $73.7M.
  • Two Sigma Investments first reported a position in Celgene Corp in Q2 2013 and held it in 20 quarters.
  • Two Sigma Investments's Celgene Corp position peaked at $183M in Q2 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Two Sigma Investments's 13F filing for Q4 2019, filed 14 Feb 2020.